Some considerations for treatment of spasmodic torticollis. Clinical and experimental studies.
D000547:Amantadine / Q000627:therapeutic use; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D002395:Catecholamines / Q000032:analysis; D002415:Cats; D002421:Caudate Nucleus / Q000032:analysis; D004195:Disease Models, Animal; D004298:Dopamine / Q000627:therapeutic use; D005625:Frontal Lobe / Q000032:analysis; D006624:Hippocampus / Q000601:surgery*; D006801:Humans; D007031:Hypothalamus / Q000032:analysis; D009778:Occipital Lobe / Q000032:analysis; D012701:Serotonin / Q000032:analysis / Q000627:therapeutic use; D013238:Stereotaxic Techniques; D013681:Tegmentum Mesencephali / Q000502:physiology*; D013788:Thalamus / Q000032:analysis; D014103:Torticollis / Q000188:drug therapy / Q000378:metabolism / Q000601:surgery / Q000628:therapy*
D001679:Biogenic Amines; D002395:Catecholamines; D012701:Serotonin; D000547:Amantadine; D004298:Dopamine